Crinetics Pharmaceuticals (CRNX) EBITDA Margin (QoQ) (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 8.74 Bn | 7.45 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86,176.00 |
| Dec 31, 2025 | 9.75 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Jun 30, 2024 | -925,871.00 |
| Sep 30, 2023 | -1.17 Mn |
| Jun 30, 2023 | -357,297.00 |
| Mar 31, 2023 | 491,658.00 |
| Dec 31, 2022 | 278,030.00 |
| Sep 30, 2022 | 31,747.00 |
| Jun 30, 2022 | -872,485.00 |
| Mar 31, 2022 | 178,492.00 |
| Mar 31, 2020 | -2.03 Mn |
| Dec 31, 2019 | -172,392.00 |
| Mar 31, 2019 | -152,923.00 |
| Dec 31, 2018 | 26,507.00 |
| Sep 30, 2018 | -60,764.00 |
| Jun 30, 2018 | 38,523.00 |
| Mar 31, 2018 | -77,655.00 |
| Dec 31, 2017 | -10,274.00 |